| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e433390a4cb971d108fb8f4734f32992
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8daf5cfe760281ae67e47e53572610de
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7cb178c55fd190972ba5f3dddb158570
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_51340549f4125fbd79387feb8f555b87 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-70539
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-74
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-85 |
| filingDate |
2003-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3b9acfd8fee29097ff00596189c9bfb7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2098412f43fb77b0fc17368808dfb656
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b645e68386fe7f1c3fe608bf6981e9a3 |
| publicationDate |
2003-12-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03102186-A1 |
| titleOfInvention |
Dna inducing cancer cell-specific expression and cancer cell-specific expression vector |
| abstract |
It is intended to provide a DNA inducing cancer cell-specific expression which causes gene expression specifically in cancer cells and a recombinant vector containing this DNA. More specifically speaking, a DNA containing at least a part of a DNA having +22 bases from the 5’-upper 2667 base starting with the transcription initiation point of Q5 antigen gene of a mouse non-classical histocompatible antigen gene (MHC class Ib gene) (SEQ ID NO:1), and a vector containing the same. It is also ntended to provide a method which comprises transferring a vector containing the above DNA together with a nucleotide sequence encoding a target protein, a target polypeptide or RNA into cancer cells and expressing the target polypeptide or RNA specifically in the cancer cells. The above vector is applicable to the prevention, treatment and diagnosis of cancer. It is also possible to develop a novel gene therapy method for cancer and a cancer vaccine. |
| priorityDate |
2002-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |